Trial Details
RECRUITINGBasic Information
| Clinical ID | c1331 |
|---|---|
| Identifier | NCT05186623 |
| Trial Title | Prediction Model for Response to Biologics and Small Molecular Agent for UC |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Vedolizumab, Ustekinumab, or Tofacitinib |
Participant Information
| Sponsor | Asan Medical Center |
|---|---|
| City | Seoul |
| Country/Region | South Korea |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2022-02-05 |
|---|---|
| Primary Completion Date | 2026-12-31 |
| Completion Date | 2026-12-31 |